The Apex Times
Above the Noise
Politics Wire
PoliticsSenate leaders plan funding stopgap and sanctions package to end session before monthlong summer recessThe Apex TimesPoliticsTrump returns to White House Correspondents’ Dinner stage after gunfire evacuation incident, Fox reportsThe Apex TimesPoliticsTrump hosts nuclear power executives in Oval Office event touting accelerated domestic reactor developmentThe Apex TimesPoliticsTrump says four new nuclear power projects met an administration goal by July 4The Apex TimesPoliticsCory Mills says reported Justice Department investigation is a “political op” ahead of Florida Republican primaryThe Apex TimesPoliticsDNC Rules panel votes to keep South Carolina as the first 2028 Democratic presidential primary stateThe Apex TimesPoliticsPresident Donald Trump orders Smithsonian to post new public disclaimers outside the Museum of American HistoryThe Apex TimesPoliticsTrump links Iran to costs for reopening the Strait of Hormuz as nuclear talks stall, but end-of-war conditions remain undefinedThe Apex TimesPoliticsHobbs reelection campaign outspent its haul in Q2, GOP critic cites “drunken sailor” spendingThe Apex TimesPoliticsSt. Louis Democratic House primary rematch spotlights Israel rift in early appearancesThe Apex TimesPoliticsPBS NewsHour panel discusses Iran conflict’s economic and human toll, U.S.-Saudi nuclear energy deal, and GOP primary wins by election deniersThe Apex TimesPoliticsMaine Democrats convene to choose a new candidate after Graham Platner’s campaign troublesThe Apex TimesPoliticsSenate leaders plan funding stopgap and sanctions package to end session before monthlong summer recessThe Apex TimesPoliticsTrump returns to White House Correspondents’ Dinner stage after gunfire evacuation incident, Fox reportsThe Apex TimesPoliticsTrump hosts nuclear power executives in Oval Office event touting accelerated domestic reactor developmentThe Apex TimesPoliticsTrump says four new nuclear power projects met an administration goal by July 4The Apex TimesPoliticsCory Mills says reported Justice Department investigation is a “political op” ahead of Florida Republican primaryThe Apex TimesPoliticsDNC Rules panel votes to keep South Carolina as the first 2028 Democratic presidential primary stateThe Apex TimesPoliticsPresident Donald Trump orders Smithsonian to post new public disclaimers outside the Museum of American HistoryThe Apex TimesPoliticsTrump links Iran to costs for reopening the Strait of Hormuz as nuclear talks stall, but end-of-war conditions remain undefinedThe Apex TimesPoliticsHobbs reelection campaign outspent its haul in Q2, GOP critic cites “drunken sailor” spendingThe Apex TimesPoliticsSt. Louis Democratic House primary rematch spotlights Israel rift in early appearancesThe Apex TimesPoliticsPBS NewsHour panel discusses Iran conflict’s economic and human toll, U.S.-Saudi nuclear energy deal, and GOP primary wins by election deniersThe Apex TimesPoliticsMaine Democrats convene to choose a new candidate after Graham Platner’s campaign troublesThe Apex TimesPoliticsSenate leaders plan funding stopgap and sanctions package to end session before monthlong summer recessThe Apex TimesPoliticsTrump returns to White House Correspondents’ Dinner stage after gunfire evacuation incident, Fox reportsThe Apex TimesPoliticsTrump hosts nuclear power executives in Oval Office event touting accelerated domestic reactor developmentThe Apex TimesPoliticsTrump says four new nuclear power projects met an administration goal by July 4The Apex TimesPoliticsCory Mills says reported Justice Department investigation is a “political op” ahead of Florida Republican primaryThe Apex TimesPoliticsDNC Rules panel votes to keep South Carolina as the first 2028 Democratic presidential primary stateThe Apex TimesPoliticsPresident Donald Trump orders Smithsonian to post new public disclaimers outside the Museum of American HistoryThe Apex TimesPoliticsTrump links Iran to costs for reopening the Strait of Hormuz as nuclear talks stall, but end-of-war conditions remain undefinedThe Apex TimesPoliticsHobbs reelection campaign outspent its haul in Q2, GOP critic cites “drunken sailor” spendingThe Apex TimesPoliticsSt. Louis Democratic House primary rematch spotlights Israel rift in early appearancesThe Apex TimesPoliticsPBS NewsHour panel discusses Iran conflict’s economic and human toll, U.S.-Saudi nuclear energy deal, and GOP primary wins by election deniersThe Apex TimesPoliticsMaine Democrats convene to choose a new candidate after Graham Platner’s campaign troublesThe Apex TimesPoliticsSenate leaders plan funding stopgap and sanctions package to end session before monthlong summer recessThe Apex TimesPoliticsTrump returns to White House Correspondents’ Dinner stage after gunfire evacuation incident, Fox reportsThe Apex TimesPoliticsTrump hosts nuclear power executives in Oval Office event touting accelerated domestic reactor developmentThe Apex TimesPoliticsTrump says four new nuclear power projects met an administration goal by July 4The Apex TimesPoliticsCory Mills says reported Justice Department investigation is a “political op” ahead of Florida Republican primaryThe Apex TimesPoliticsDNC Rules panel votes to keep South Carolina as the first 2028 Democratic presidential primary stateThe Apex TimesPoliticsPresident Donald Trump orders Smithsonian to post new public disclaimers outside the Museum of American HistoryThe Apex TimesPoliticsTrump links Iran to costs for reopening the Strait of Hormuz as nuclear talks stall, but end-of-war conditions remain undefinedThe Apex TimesPoliticsHobbs reelection campaign outspent its haul in Q2, GOP critic cites “drunken sailor” spendingThe Apex TimesPoliticsSt. Louis Democratic House primary rematch spotlights Israel rift in early appearancesThe Apex TimesPoliticsPBS NewsHour panel discusses Iran conflict’s economic and human toll, U.S.-Saudi nuclear energy deal, and GOP primary wins by election deniersThe Apex TimesPoliticsMaine Democrats convene to choose a new candidate after Graham Platner’s campaign troublesThe Apex Times
Back to front
FDA advisory panel votes to expand list of substances pharmacies may compound, adding peptides despite agency scientists’ objections
The Apex Times

THE APEX TIMES

Politics/The Apex Times/Jul 25, 5:09 AM EDT

FDA advisory panel votes to expand list of substances pharmacies may compound, adding peptides despite agency scientists’ objections

The FDA’s Pharmacy Compounding Advisory Committee backed adding peptides to the agency’s permitted compounding list after a public meeting that included comments and presentations from FDA staff.

2 min readEditor-approved Apex article

The Food and Drug Administration’s Pharmacy Compounding Advisory Committee voted to add peptides to the list of substances that compounding pharmacies may make, breaking with the position of agency scientists during a public meeting held this week, according to reporting by The Hill.

The vote came after the committee received public comment and heard presentations from FDA staffers describing the scientific issues raised for peptides, the report said. The agency scientists’ opposition centered on concerns about the basis for adding peptides, including questions about whether benefits have been demonstrated to support broad allowance for compounding.

Pharmacy compounding generally involves tailoring medications for individual patients, but it also operates within FDA rules that determine which ingredients are eligible for certain compounding activities. The permitted list is designed to provide a clearer regulatory pathway for compounding pharmacies, while still reflecting FDA’s assessment of the substances involved.

At the meeting, the committee considered the requested expansion of the permitted compounding category for peptides while weighing the concerns presented by FDA scientists, The Hill reported. The panel’s decision to move forward with adding peptides means the committee recommended that the ingredient be included among substances pharmacies can compound under the program’s framework.

FDA scientists had argued against adding the peptides, the report said, pointing to the agency’s views on the evidentiary record and the degree of demonstrated benefit. The panel nonetheless supported adding the substance, a step that can influence how FDA proceeds with regulatory updates tied to the advisory committee’s recommendations.

While the committee’s vote is advisory, the decision is part of a formal process in which FDA officials consider expert input and public comments as they determine how to handle compounding-related policy changes. The practical effect for pharmacies and patients depends on subsequent FDA actions that follow the committee’s recommendation.

Why It Matters

  • Expanding the permitted compounding list can change what ingredients pharmacies are eligible to compound under FDA’s compounding framework, with downstream implications for availability.
  • The panel’s vote highlights a recurring tension between agency scientific concerns and expert committee recommendations during FDA’s deliberative process.
  • Because the advisory committee’s decision must still be followed by FDA implementation steps, the timeline for any policy change will depend on the agency’s next actions after the vote.

Sources

Key Facts

  • On July 23, the FDA’s Pharmacy Compounding Advisory Committee voted to add peptides to the permitted list of substances that compounding pharmacies can make.
  • The committee broke with the position of FDA agency scientists who had opposed adding peptides.
  • The public meeting included public comments and presentations from FDA staffers raising scientific concerns related to peptides.
  • The decision is tied to the FDA’s compounded drugs policy process and the advisory committee’s recommendations.
FDA advisory panel votes to expand list of substances pharmacies may compound, adding peptides despite agency scientists’ objections | The Apex Times